CANCER- MELANOMA Flashcards
There are two types of non-melanoma skin cancers, what are these?
Basal Cell carcinoma
Squamous cell carcinoma
Where is melanoma commonly found in women and men?
Men: backs and faces
Women: arms and legs
We use the ABCDEF system to identify melanomas. What does this stand for?
A: Asymmetrical B: Border C: colour (colour varies throughout) D: Diameter (larger than a pencil eraser) E: Elevation off the skin F: Funny mole
What are the risk factors for melanoma?
Sun exposure: Exposure to intermittent intense sun is more of a risk than prolonged exposure to UV radiation. Blistering sun burn in childhood a risk!!
Number of Moles
Skin type: Fair haired pale skin more likely
Family history
What does diagnosis of Melanomas involve?
patients usaully present with a changing or enlarging or irritating lesion
Mole examined under a dermascope
Excisional biopsy done to remove whole lesions
Histopathology: to determine stage and type of melanoma
Physical examination: lymphadenopathy (see if its spread to lymph nodes)
How do we treat stage 0/1/2/3 melanoma tumours?
Excision of the tumour followed by wide local excision to remove a good margin of the healthy tissue
How do we treat stage 4 melanoma tumours?
these are advanced tumours and are resectable (i.e. they can’t be cut out)
We treat with chemotherapy
Can use biological therapies: ipilimumab, vemurafenib
What is the prognosis with Advanced/ unresectable melanoma (stage 4)?
10 year survival is under 10%
Ipilimumab was the first agent to show an increase in overall survival in advanced/ unresectable malignant melanomas. What is this?
A recombinant human monoclonal antibody that will bind to CTLA-4 and block its interaction with its ligands CD80 and CD86.
It is recommended for use after a previous therapy has been tried (e.g. chemotherapy drug Dacarbazine) as its the most expensive cancer drug
Ipilimumab works by blocking CTLA-4. Its mechanism of action is INDIRECT possibly through T cell mediated anti tumour responses. What does this mean?
CTLA-4 is a molecule that serves as an immune checkpoint that results in down regulation of T-cell activation. This therefore prevents the immune system attacking cancer cells.
By blocking CTLA-4’s action, Ipilimumab stimulates the anti-tumour T cell response and lots of T cells are produced through unrestrained T cell proliferation
Remember: Ipilumumab blocks CTLA-4’s action which TURNS T CELLS ON
It therefore has an indirect action: it doesn’t kill the cell directly but makes the immune system do it!!
What are the side effects of Ipilumumab??
Diarrhoea Rash Pruritus Fatigue Nausea & vomitting Decreased appetite Abdominal pain
Advanced/ unresectable melanoma (stage 4) can be treated using Dacarbazine. what is this?
Chemotherapy agent
A DNA alkylating drug
No significant effect on overall survival
What drug can be used in patients that have the BRAF V600 gene mutation?
Vemurafenib
Its a BRAF (a tyrosine kinase) inhibitor
Its an oral drug
Vemurafenib is a GOOD drug in Malignant melanoma treatment.
Around 90% of patients have tumour regression quickly when treated with this drug!
Overall median survival is 15 months